| 标题 |
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:EClinicalMedicine 作者:Linong Ji; Leili Gao; Hongwei� Jiang; Jing Yang; Lei Yu; et al 出版日期:2022-10-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)